InterMune (ITMN) Shares Jump as Esbriet Receives Favorable Score in France; Wells Fargo Comments

Article Stock Quotes (1) Comments (0)

Shares of InterMune (Nasdaq: ITMN) have rallied sharply Thursday afternoon following a mid-day research note from Wells Fargo.

The firm said France's Committee de la Transparence rendered a final decision on the company's Esbriet, issuing a "4" ASMR score (a minor improvement). Although such a score suggests Esbriet will be priced similarly to comparable therapies for IBF, Wells Fargo said, "with no comparable drugs for pricing reference for Esbriet, we believe ITMN can still negotiate premium pricing (we do not believe off-label use of NAC would be considered as an appropriate comparable for pricing references.)"

Wells Fargo maintains an Outperform rating on shares of InterMune.

The stock is up about 7 percent at last check.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
• Response Genetics (RGDX) Surges on Blue Shield of California Contract
• SolarCity (SCTY) is 'Hot, Hot, Hot', But Questions About Financing Deal Raised

Create E-mail Alert Related Categories

Analyst Comments, Corporate News, Momentum Movers

Related Entities

Wells Fargo

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?